SARCOMA UK

Registered charity 1139869 · accounts filings on the Charity Commission register · Wikidata: Q30273026 · also registered in Scotland as SC044260 (OSCR)

Our mission is to ensure everyone affected by sarcoma receives the best treatment, care, information and support available and to create the treatments of the future. We drive awareness of sarcoma cancer, find answers through funding sarcoma research, provide information and support to anyone affected by sarcoma cancer, campaign for better treatments and to improve standards of care.

Objects

2.1 TO PROMOTE AND PROTECT THE PHYSICAL AND MENTAL HEALTH OF PATIENTS WITH BONE AND SOFT TISSUE SARCOMAS IN THE UNITED KINGDOM THROUGH THE PROVISION OF INFORMATION, SUPPORT, EDUCATION AND PRACTICAL ADVICE TO THEM, THEIR FAMILIES AND THEIR CARERS;2.2 THE RELIEF OF SICKNESS AND THE PRESERVATION OF HEALTH IN PARTICULAR BY PROMOTING AND SUPPORTING RESEARCH WITH THE PUBLICATION OF THE USEFUL RESULTS THEREOF AND THE DEVELOPMENT OF MORE EFFECTIVE TREATMENT AND CARE FOR PATIENTS WITH BONE AND SOFT TISSUE SARCOMAS;2.3 TO ADVANCE THE EDUCATION OF THE GENERAL PUBLIC IN ALL AREAS RELATING TO SARCOMA.

Area of benefit: NATIONAL.

The charity’s charitable objects and area of benefit, quoted from its governing document as held on the Charity Commission register.

Causes: General Charitable Purposes · The Advancement Of Health Or Saving Of Lives · Other Charitable Purposes · website · Get email alerts

Registered contact address: Islington, London, England (from the postcode on the register)

Latest income
£4.6m
Latest spending
£4.5m
Registered
2011
Accounts read
FY2025

Financial health, per its FY2025 accounts

The accounts state that Sarcoma UK reported a surplus of £101,258 for the year ended 31 March 2025, increasing total charity funds to £1,904,765. The trustees confirm that unrestricted reserves of £1,897,204 significantly exceed the stated policy target of approximately £963,000, representing six months of operational costs. The auditor reported no material uncertainties regarding the charity's ability to continue as a going concern.

Automated summary of the FY2025 accounts; the evidenced findings below carry the verbatim passages.

What the accounts disclose

Fundraising cost ratio: 26.0% of fundraised income, as disclosed
“We also focus on minimising fundraising costs, with just 26% of our expenditure spent on raising funds, demonstrating the efficiency of our fundraising approach.”
Per its FY2025 accounts as filed with the Charity Commission.
Reserves policy: six months of operational costs including budgeted salary, rent and support costs (reserves figure: £1.9m)
“The Board of Trustees aim to maintain reserves at a level which equates to approximately six months of operational costs including budgeted salary, rent and support costs. This is approximately £963,000 for the forthcoming year.” — page 32
Per its FY2025 accounts as filed with the Charity Commission.
Related-party transaction: Sarcoma UK Trustees and close family personally donated and raised £74,531 (2024: £12,966), including funds raised through challenge events such as the London Marathon.
“Sarcoma UK Trustees and close family personally donated and raised £74,531 (2024: £12,966), including funds raised through challenge events such as the London Marathon.” — page 49
Per its FY2025 accounts as filed with the Charity Commission.

Accounts audited by Sayer Vincent LLP. Discloses 4 of 6 completeness components.

Policies the charity declares

In its annual return the charity told the Commission that it has the policies listed below. This is self-declared: it is not verified by the Commission or by this site, and it is not evidence of how a policy works in practice.

From the charity’s annual return (Part A, self-declared)

Answers and figures the charity gave in Part A of its annual return to the Charity Commission. They are self-declared: not verified by the Commission or by this site. Only positive answers and figures are listed; items not listed are simply not shown.

Self-declared on the annual return for the financial year ending 31/03/2025

  • Volunteers: 55
  • Employees paid over £60,000: 4 (£60,001–£70,000: 1; £80,001–£90,000: 2; £120,001–£130,000: 1)

Self-declared on the annual return for the financial year ending 31/03/2024

  • Volunteers: 65
  • Government income: £385,671 — grants £385,671 (1); 10% of the £3,840,681 total gross income on the same return
  • Employees paid over £60,000: 3 (£70,001–£80,000: 2; £100,001–£110,000: 1)

Self-declared on the annual return for the financial year ending 31/03/2023

  • Volunteers: 60
  • Government income: £293,388 — grants £293,388 (1); 10% of the £2,889,367 total gross income on the same return
  • Employees paid over £60,000: 3 (£70,001–£80,000: 2; £110,001–£120,000: 1)

Source: this charity’s annual returns on the Charity Commission register.

Public fundraising profile: JustGiving — Sarcoma UK (matched by registered charity number).

Public profiles (found on the charity’s own website): facebook · instagram

Structured financials (annual return, FY ending 31/03/2025)

Total income
£4.6m
Total spending
£4.5m
Cost of raising funds
£1.2m
Reserves (reported)
£422k
Employees
32

Reported reserves equal ~1.1 months of spending — in the bottom quarter for charities its size (median 4.7 months; benchmarks).

Per its annual return, cost of raising funds: 25.6% of total income — in the top quarter for charities its size (median 5.3%) (benchmarks).

Trustees · trustee networks

Trustee list from the Charity Commission register (current, not historical).

Operates in: Northern Ireland · Scotland · Throughout England And Wales

Income and spending

Financial year endIncomeSpending
31/03/2025£4.6m£4.5m
31/03/2024£3.8m£3.5m
31/03/2023£2.9m£2.9m
31/03/2022£2.5m£2.4m
31/03/2021£1.9m£1.9m

Common questions

Is SARCOMA UK financially healthy?

Per its FY2025 accounts: The accounts state that Sarcoma UK reported a surplus of £101,258 for the year ended 31 March 2025, increasing total charity funds to £1,904,765. The trustees confirm that unrestricted reserves of £1,897,204 significantly exceed the stated policy target of approximately £963,000, representing six months of operational costs. The auditor reported no material uncertainties regarding the charity's ability to continue as a going concern. Its FY2025 accounts were audited by Sayer Vincent LLP.

Who funds SARCOMA UK?

Funders whose own accounts filings name SARCOMA UK as a grant recipient include BONE CANCER RESEARCH TRUST, THE LENNOX HANNAY CHARITABLE TRUST, THE RANDAL CHARITABLE FOUNDATION, THE EMMANUEL KAYE FOUNDATION, ROBERT LUFF FOUNDATION LIMITED.

Known funders

Grants to this charity found in funders’ own accounts filings.

FunderYearAmountPurpose (as stated by the funder)
BONE CANCER RESEARCH TRUSTFY2021£43kImproving outcome in Sarcoma through Analysis and interrogation of National Cancer Data
THE LENNOX HANNAY CHARITABLE TRUSTFY2022£25kThe advancement of health or the saving of lives
THE RANDAL CHARITABLE FOUNDATIONFY2024£20k
THE RANDAL CHARITABLE FOUNDATIONFY2025£20kGrant to institutions
THE EMMANUEL KAYE FOUNDATIONFY2025£20k
ROBERT LUFF FOUNDATION LIMITEDFY2022£20k
THE ALICE ELLEN COOPER-DEAN CHARITABLE FOUNDATIONFY2022£15k
THE EMMANUEL KAYE FOUNDATIONFY2024£15k
THE ALICE ELLEN COOPER-DEAN CHARITABLE FOUNDATIONFY2021£10k
THE WILL CHARITABLE TRUSTFY2022£10kCancer Care
THE ALICE ELLEN COOPER-DEAN CHARITABLE FOUNDATIONFY2023£10k
THE CATHERINE COOKSON CHARITABLE TRUSTFY2024£10kMedical, Health and Sickness
ROBERT LUFF FOUNDATION LIMITEDFY2021£10k
THE ALICE ELLEN COOPER-DEAN CHARITABLE FOUNDATIONFY2024£10k
THE WILL CHARITABLE TRUSTFY2021£10kCare of Cancer Patients
THE EMMANUEL KAYE FOUNDATIONFY2023Unverified read£10kSeesaw Trusts
PILKINGTON CHARITIES FUNDFY2023£6k
MILLES CHARITABLE FOUNDATION LIMITEDFY2025£5kGrant making
THE CHRISTOPHER AND HENRY OLDFIELD TRUSTFY2022£5k
THE BUZZACOTT STUART DEFRIES MEMORIAL FUNDFY2025£5k
THE FREDDIE GREEN AND FAMILY CHARITABLE FOUNDATIONFY2025£5k
THE CHRISTOPHER AND HENRY OLDFIELD TRUSTFY2023£5k
THE FREDDIE GREEN AND FAMILY CHARITABLE FOUNDATIONFY2023£5k
SANDRA CHARITABLE TRUSTFY2024£5kGrant paid or payable
THE GROCERS' CHARITYFY2025£4kHealth
CLAN TRUST LIMITEDFY2023£4k
THE BILLMEIR CHARITABLE TRUSTFY2025£3k
THE BILLMEIR CHARITABLE TRUSTFY2024£3k
GIDDO'S GIFTFY2026£3kEngineering cancer busting viruses for sarcoma
SANDRA CHARITABLE TRUSTFY2025£3k
THE ANNABEL ARBIB FOUNDATIONFY2021£3kMedical
WHITAKER CHARITABLE TRUSTFY2024£2k
THE PHILIP OPPENHEIMER FOUNDATIONFY2026£2k
THE BILLMEIR CHARITABLE TRUSTFY2023£2kDonations
THE PAROCHIAL CHURCH COUNCIL OF THE ECCLESIASTICAL PARISH OF SOUTH GILLINGHAMFY2024£1kChurch Shop Distribution
THE W H SMITH GROUP CHARITABLE TRUSTFY2022£1k
CBRE UK CHARITABLE TRUSTFY2025£1k
CLAN TRUST LIMITEDFY2025£1k
THE OAKDALE TRUSTFY2024£1k
THE W H SMITH GROUP CHARITABLE TRUSTFY2023£1k
CLAN TRUST LIMITEDFY2024£1k
ALTOR FOUNDATIONFY2025£1kSupporting patients and their families with a diagnosis of Sarcoma a soft-tissue cancer.
WHITAKER CHARITABLE TRUSTFY2022£1k
CBRE UK CHARITABLE TRUSTFY2023Unverified read£500
CBRE UK CHARITABLE TRUSTFY2022£300
THE FREDDIE GREEN AND FAMILY CHARITABLE FOUNDATIONFY2024amount not stated
THE PETER STEBBINGS MEMORIAL CHARITYFY2025amount not stated
THE PHILIP J MILTON AND COMPANY PLC CHARITABLE FOUNDATIONFY2022amount not statedResearching and relieving this evil cancer in sufferers and their families

Grants marked “Unverified read” were flagged by automated checks as possibly misread from the funder’s filed accounts. They are listed, but left out of the totals, counts and funder relationships this site computes.

Funders of similar charities

Funders whose accounts show grants to charities similar to this one (and no recorded grant to this charity) — a starting list for fundraisers.

Charities like this

Semantically similar by activities and financial character, from our analysed corpus. Compare with BRITISH SARCOMA GROUP.

Side by side with its peers

CharityIncomeTop pay bandStaff >£60kReserves vs policyFundraising costGoing concern
SARCOMA UK£4.6m——above26.0%no doubt
BRITISH SARCOMA GROUP FY2025£184k——above—no doubt
JESSICA'S SARCOMA AWARENESS FY2025£67k—0unclear—no doubt
SARCOIDOSISUK FY2025£185k—0unclear—no doubt
Melanoma UK FY2025£212k—0above2.3%no doubt
FIGHTING ALL CANCERS TOGETHER FY2025£554k—0below—no doubt

Each row is that charity’s latest analysed filing; every value is quote-backed on its own page.